Korean APIs Ascend Global Supply Chain on Quality Trust

South Korean pharmaceutical ingredients (APIs) are carving out a significant niche in the global market, shifting from a focus on price to one of quality and reliability. The nation's APIs are now making inroads into developed markets, including Japan, the United States, and Europe, a trend industry experts attribute to robust impurity management and adherence to international quality standards. "We are gaining global trust in areas like impurity management," stated Han Ssang-soo, CEO of Inist ST, a company with a US FDA-approved API plant for anti-cancer drugs in Osong. He highlighted that Korean APIs are manufactured and managed to meet global standards, enhancing their competitiveness abroad. This reputation is crucial, as APIs are the core components of medicines, directly impacting the safety and efficacy of finished pharmaceutical products. Regulatory bodies like the US Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Japan's Pharmaceuticals and Medical Devices Agency (PMDA) impose stringent manufacturing and quality control requirements. In response, the Korean pharmaceutical industry has continuously strengthened its production and quality management systems. A key development was the Ministry of Food and Drug Safety's 2020 revision of its Good Manufacturing Practice (GMP) guidelines, incorporating standards from the Pharmaceutical Inspection Co-operation Scheme (PIC/S), a global body promoting harmonization of GMP and inspection practices. This updated guideline includes critical quality requirements such as impurity control and data integrity, which are highly valued by global regulatory agencies. Industry insiders believe this has provided a foundation for domestic API manufacturers to establish international-standard quality systems. Companies are investing in production facilities compliant with current Good Manufacturing Practices (cGMP), enhancing impurity management, standardizing manufacturing processes, and strengthening data management systems to better serve global clients. The government's systematic quality management framework also bolsters the industry. Beyond initial GMP certification, API manufacturers undergo continuous post-management. Korea employs a risk-based management system that considers the quality level, production history, and risk factors of manufacturing sites, supplemented by regular and ad-hoc inspections. This ongoing oversight ensures consistency and reliability in manufacturing quality, making Korean APIs attractive for the global supply chain.

“

We are gaining global trust in areas like impurity management.